Introduction Are you uninsured? If you do have health coverage, are your prescription co-pays or other co-insurance costs prohibitively expensive? Or does your plan come with high medication deductibles that you can’t afford? Help may be available from pharmaceutical companies and other organizations in the form of co-pay programs and patient assistance programs (PAPs). In recent years, the Fair Pricing Coalition (FPC) has been working closely with the pharmaceutical industry to streamline access to co-pay programs and PAPs for people living with viral hepatitis. The FPC has negotiated co-pay programs with virtually every major hepatitis drug manufacturer. Below is a list of co-pay and patient assistance programs for hepatitis B and C, including contact information for these programs. Different pharmaceutical company programs have different eligibility criteria based on the federal poverty level (FPL). Eligibility for this year is based on last year’s income. The figure is adjusted based on family or household size. A complete table is available here. Unless otherwise stated, companies ask for verification of income, usually in the form of a federal income tax return. Companies also generally consider household income, meaning that a married couple filing joint taxes will be judged on their combined income. People who file individual tax returns will only have their individual income considered. If you are told you are ineligible for assistance, this does not mean there is no chance for you; you can always appeal to have the decision reversed or see if you are eligible for alternative financial assistance. Co-pay and PAP Programs Co-pay programs offer assistance to people with private insurance, reducing the co-payments or coinsurance costs required to obtain hepatitis C drugs at the pharmacy. Many of these programs are not available for those enrolled in Medicare, Medicaid, or other government-based prescription plan. Patient assistance programs (PAPs) offer free hepatitis C drugs to lower-income people who are uninsured or underinsured, and who do not qualify for insurance programs such as Medicaid or Medicare. If you are ineligible for co-pay or patient assistance funds because you have Medicare, Medicaid or another government-based prescription plan, and cannot afford your prescription(s), ask the pharmaceutical company to refer you to a patient advocacy organization (some are listed below). Asegua Therapeutics LLC (Gilead Sciences subsidiary) Drugs covered: sofosbuvir/velpatasvir (generic form of Epclusa ), l edipasvir/sofosbuvir (generic form of Harvoni) Contact Information: 855-7MY-PATH (855-769-7284) or www.MySupportPath.com; Asegua Therapeutics www.asegua.com/patient-support Program Details: Offers co-pay assistance and free drug programs for those meeting eligibility requirements. AbbVie Inc. Drugs covered: Mavyret ( glecaprevir + pibrentasvir ), Moderiba (ribavirin) Contact Information: For Mavyret 877-628-9738 or www.mavyret.com. For Moderiba 844-663-3742 or www.abbvie.com/patients/patient-assistance.html or www.rxabbvie.com Program Details: Offers co-pay assistance and free drug programs for those meeting eligibility requirements. Bristol-Myers Squibb (BMS) Drugs covered: Daklinza (daclatasvir) Contact Information: 844-44CONNECT (844-442-6663) or https://www.bms.com/patient-and-caregivers/our-medicines.html Program Details: Offers co-pay assistance and free drug programs for those meeting eligibility requirements. Genentech/Roche Drugs covered: Pegasys (peginterferon alfa-2a) and Copegus (ribavirin) Contact Information: 888-941-3331 or www.genentech-access.com/pegasys/patients Program Details: Offers co-pay assistance and free drug programs for those meeting eligibility requirements. Gilead Sciences Drugs covered: Epclusa ( sofosbuvir/velpatasvir ), Harvoni (ledipasvir/sofosbuvir), Sovaldi (sofosbuvir), Vosevi (sofosbuvir/velpatasvir/voxilaprevir) Contact Information: 855-7MY-PATH (855-769-7284) or www.MySupportPath.com Program Details: Offers co-pay assistance and free drug programs for those meeting eligibility requirements. Merck Drugs covered: Zepatier ( elbasvir/grazoprevir) Contact Information: 866-251-6013 or www.merckaccessprogram-zepatier.com/hcc Program Details: Offers co-pay assistance and free drug programs for those meeting eligibility requirements. Kadmon Pharmaceuticals Drugs covered: Ribasphere (ribavirin) Contact Information: 877-377-7862 or www.ribapak.com/index.html Program Details: Offers co-pay assistance and free drug programs for those meeting eligibility requirements. Other Patient Advocacy Programs In addition to pharmaceutical patient assistance and co-pay programs, patient advocacy programs may help you find affordable medication and navigate other issues relating to access to care. HealthWell Foundation Contact Information: 800-675-8416 or www.healthwellfoundation.org/hepatitis-c Program Details: The HealthWell Foundation provides financial assistance to eligible individuals to cover coinsurance, copayments, health care premiums and deductibles for certain medications and therapies. Help-4-Hep Contact Information: 877-HELP4HEP (877-435-7443) or www.help4hep.org Program Details: Help-4-Hep is a nonprofit, peer-to-peer helpline where counselors work with patients to meet the challenges of hepatitis C. Help-4-Hep provides information and resources about finding financial help to pay for low cost testing, or finding a free or low cost clinic, or financial help with payment for treatments. They may also help find doctors and support groups. Services are provided free of charge. Partnership for Prescription Assistance (PPA) Contact Information: 888-477-2669 or www.pparx.org Program Details: The Partnership for Prescription Assistance helps qualifying patients without prescription drug coverage get the medicines they need by matching them with the right assistance programs. Patient Advocate Foundation’s Hepatitis C CareLine Contact Information: 800-532-5274 or www.hepatitisc.pafcareline.org Program Details: Patient Advocate Foundation’s Hepatitis C CareLine is a hotline for patients and providers that provides assistance to patients who have been diagnosed with hepatitis C and are seeking education and access to care. Patient Access Network Foundation (PAN) Contact Information: 866-316-PANF (866-316-7263) or www.panfoundation.org Program Details: The Patient Access Network Foundation offers help to people with chronic or life-threatening illnesses for whom cost limits access to medical treatments. HCV-HIV Coinfection To find patient assistance and co-pay programs if you are coinfected with HCV and HIV, additional help is available at: HIV Drug Assistance Programs. The information on this page is based on a document originally produced by the Fair Pricing Coalition, an ad hoc group of activists who advocate with the pharmaceutical industry regarding the price and patient access to HIV and viral hepatitis drugs. For more information, please visit www.fairpricingcoalition.org.